As the report of the holdings for the second quarter has come out for Berkshire Hathaway, there are a few surprises there: they have increased their stake of Apple by 75,000,000 – and the total now is almost 240,000,000. In dollar terms, the holdings are worth a little bit over 50 billion dollars. Teva Pharmaceutical – not the best performer in the biotech space – was another beneficiary of Berkshire Hathaway. Buffett also has done some reshuffling in his airline holdings: they added to Delta Air Lines, Southwest Air and trimmed their holdings of United Continental.
As we know, Warren Buffet is a big fan of Wells Fargo – or at least he has been for many years but ever persisting scandals apparently are starting to take tall even on the most religious believers – Berkshire trimmed their holdings of Wells Fargo and increased their holdings of iconic Goldman Sachs. Apparently, Mr. Buffet cannot forget these very profitable preferred convertibles he got from Goldman Sachs during the financial crisis.
The Moving Average Convergence Divergence (MACD) for GS turned positive on September 09, 2025. Looking at past instances where GS's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 22, 2025. You may want to consider a long position or call options on GS as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GS advanced for three days, in of 341 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 308 cases where GS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
GS broke above its upper Bollinger Band on September 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. GS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.186) is normal, around the industry mean (33.721). P/E Ratio (17.330) is within average values for comparable stocks, (71.715). Projected Growth (PEG Ratio) (2.951) is also within normal values, averaging (2.209). Dividend Yield (0.016) settles around the average of (0.036) among similar stocks. P/S Ratio (4.556) is also within normal values, averaging (1537687.875).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of investment banking, securities and asset management services
Industry InvestmentBanksBrokers